ANASTASIS BIOTEC LIMITED
Company number 10502511 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£633,482
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2016-11-29
- Employees
- 2 (2025 accounts · was 3 in 2024)
- Registered office
- 56a Haverstock Hill, London, United Kingdom, NW3 2BH
- Postcode
- NW3 2BH
- Capital
- 35 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-08-11
- Next due by
- 2027-08-25
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 5 resigned
Contact details
- Website
- anastasisbiotec.com
We are developing a novel, effective and proprietary cancer treatment
Among its peers
Top 25%
by shareholders' funds, of 41 similar companies in NW
Trading since 2016.
No.8 of the largest research and experimental development on biotechnology companies in London →
Competitors London
This company ranks 8 among research and experimental development on biotechnology in London.
The class of 2016
35%
of the 402 companies in this sector incorporated in 2016 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.